companydata.dkcompanydata.dk

Rinascibella Group ApS: Financial statements 2024

CVR: 29316082

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Rinascibella Group ApS (CVR 29316082) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 25,163 and a net result of DKK 24,225 compared with DKK -4,210 the year before. Equity in the 2024 report amounted to DKK 16,660. The solvency ratio was 30.8%.

Gross Profit
DKK 25,163
Profit/Loss
DKK 24,225
Equity
DKK 16,660
Total Assets
DKK 54,089
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-25 t.24 t.17 t.0
2023--3 t.-4 t.-8 t.0
2022--22 t.-23 t.-3 t.0
202118 t.-285 t.-292 t.20 t.-
2020152 t.39 t.-14 t.313 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Rinascibella Group ApS: The 2023 annual report is outMay 27, 2024

Rinascibella Group ApS has published its annual report for 2023. Gross profit came to DKK -3,383, and the net result was DKK -4,210.

About Rinascibella Group ApS

Rinascibella Group ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MAKKY INVEST ApS. The management consists of Mehrdad Makky. The company is owned by MAKKY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,149 and a net result of DKK -6,061 compared with DKK 24,225 the year before. Equity in the 2025 report amounted to DKK 10,599.

Source: annual report 2025, Danish Business Authority